Verhagen PCMS - Search Results

1

Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial.

Boevé LMS, Hulshof MCCM, Vis AN, Zwinderman AH, Twisk JWR, Witjes WPJ, Delaere KPJ, Moorselaar RJAV, Verhagen PCMS, van Andel G. Boevé LMS, et al. Among authors: verhagen pcms. Eur Urol. 2019 Mar;75(3):410-418. doi: 10.1016/j.eururo.2018.09.008. Epub 2018 Sep 25. Eur Urol. 2019. PMID: 30266309 Clinical Trial.

2

Prognostic factors in localised prostate cancer with emphasis on the application of molecular techniques.

Verhagen PC, Tilanus MG, de Weger RA, van Moorselaar RJ, van den Tweel JG, Boon TA. Verhagen PC, et al. Eur Urol. 2002 Apr;41(4):363-71. doi: 10.1016/s0302-2838(02)00048-9. Eur Urol. 2002. PMID: 12074805 Review.

3

Re: Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.

Verhagen PC. Verhagen PC. Eur Urol. 2007 May;51(5):1444. doi: 10.1016/j.eururo.2007.02.022. Eur Urol. 2007. PMID: 17494121 No abstract available.

4

Histopathological characteristics of lymph node metastases predict cancer-specific survival in node-positive prostate cancer.

Boormans JL, Wildhagen MF, Bangma CH, Verhagen PC, van Leenders GJ. Boormans JL, et al. BJU Int. 2008 Dec;102(11):1589-93. doi: 10.1111/j.1464-410X.2008.07904.x. Epub 2008 Aug 14. BJU Int. 2008. PMID: 18710447

5

Reduction of serum prostate-specific antigen levels following varicella-zoster infection and valaciclovir treatment in prostate cancer.

Jurhill RR, van der Veen H, van Leenders GJ, Verhagen PC. Jurhill RR, et al. Eur Urol. 2009 Aug;56(2):392-4. doi: 10.1016/j.eururo.2009.02.025. Epub 2009 Feb 28. Eur Urol. 2009. PMID: 19278776

6

Words of wisdom. Re: Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.

Verhagen PC. Verhagen PC. Eur Urol. 2009 May;55(5):1239-40. doi: 10.1016/j.eururo.2009.01.058. Eur Urol. 2009. PMID: 19650231 No abstract available.

7

Expression of the androgen-regulated fusion gene TMPRSS2-ERG does not predict response to endocrine treatment in hormone-naïve, node-positive prostate cancer.

Boormans JL, Hermans KG, Made AC, van Leenders GJ, Wildhagen MF, Collette L, Schröder FH, Trapman J, Verhagen PC. Boormans JL, et al. Eur Urol. 2010 May;57(5):830-5. doi: 10.1016/j.eururo.2009.08.013. Epub 2009 Aug 22. Eur Urol. 2010. PMID: 19716227

8

Does local treatment of the prostate in advanced and/or lymph node metastatic disease improve efficacy of androgen-deprivation therapy? A systematic review.

Verhagen PC, Schröder FH, Collette L, Bangma CH. Verhagen PC, et al. Eur Urol. 2010 Aug;58(2):261-9. doi: 10.1016/j.eururo.2010.05.027. Epub 2010 May 27. Eur Urol. 2010. PMID: 20627403 Review.

9

Current vaccination strategies for prostate cancer.

Joniau S, Abrahamsson PA, Bellmunt J, Figdor C, Hamdy F, Verhagen P, Vogelzang NJ, Wirth M, Van Poppel H, Osanto S. Joniau S, et al. Eur Urol. 2012 Feb;61(2):290-306. doi: 10.1016/j.eururo.2011.09.020. Epub 2011 Oct 3. Eur Urol. 2012. PMID: 22001436 Review.

10

Words of wisdom. Re: Vitamin E and the risk of prostate cancer. The Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Verhagen PC. Verhagen PC. Eur Urol. 2012 Sep;62(3):565-6. doi: 10.1016/j.eururo.2012.06.021. Eur Urol. 2012. PMID: 22850202 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page